Inhibition of PAF-lnduced Systemic Responses in the Rat, Guinea Pig, Dog and Primate by the Receptor Antagonist SRI 63-441

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Thrombosis and Haemostasis

• Publication date

  1986-08-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0038-1661599PMID 3775689
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for distinct systemic extravasation effects of platelet activating factor, leukotrienes B4, C4, D4 and histamine in the guinea pig.

  1986cited by this paper
• Vascular responses of platelet-activating factor in the Cebus apella primate and inhibitory profiles of antagonists SRI 63-072 and SRI 63-119.

  1986cited by this paper
• Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonist.

  1986cited by this paper
• Is platelet activating factor (PAF) a mediator of endotoxin shock?

  1985cited by this paper
• Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs.

  1985cited by this paper
• Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether.

  1985cited by this paper
• Effects of platelet-activating factor on coronary hemodynamics and coronary venous plasma levels of TXB2, 6-keto-PGF1 alpha, and leukotriene C4 immunoreactivity in the intact domestic pig heart.

  1985cited by this paper
• Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.

  1985cited by this paper
• Evidence for a Direct Effect on Vascular Permeability of Platelet-Activating Factor Induced Hemoconcentration in the Guinea Pig

  1985cited by this paper
• Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.

  1985cited by this paper
• Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig.

  1984cited by this paper
• Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine.

  1984cited by this paper
• Effect of platelet activating factor on endothelial permeability to plasma macromolecules.

  1984cited by this paper
• Evaluation of Dose and Route Effects of Platelet Activating Factor-Induced Extravasation in the Guinea Pig

  1984cited by this paper
• The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation

  1984cited by this paper
• Effect of platelet-activating factor on coronary circulation of the domestic pig.

  1984cited by this paper
• Isolation of a platelet membrane protein which binds the platelet-activating factor 1-0-hexadecyl-2-acetyl-SN-glycero-3-phosphorylcholine.

  1984cited by this paper
• Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine.

  1984cited by this paper
• Possible role of endothelium in the vasodilator response of rat thoracic aorta to platelet activating factor (PAF).

  1984cited by this paper
• Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone.

  1984cited by this paper
• Studies on the hypotensive effects of platelet activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) in rats, guinea pigs, rabbits, and dogs.

  1983cited by this paper
• Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.

  1983cited by this paper
• Acute effects of intratracheal administration of platelet-activating factor in baboons.

  1983cited by this paper
• CV-3988 - a specific antagonist of platelet activating factor (PAF).

  1983cited by this paper
• The activity of aerosolized and intracutaneous synthetic platelet activating factor (AGEPC) in rhesus monkeys with IgE-mediated airway responses and normal monkeys.

  1983cited by this paper
• Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs.

  1983cited by this paper
• Pharmacological properties of PAF-acether in the guinea-pig: Platelet-dependent and independent reactions

  1982cited by this paper
• Platelet-activating factor (PAF) in experimentally-induced rabbit acute serum sickness: role of basophil-derived PAF in immune complex deposition.

  1982cited by this paper
• Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon.

  1981cited by this paper
• Alkyl Ether Analogs of Phosphatidylcholine Are Orally Active in Hypertensive Rabbits

  1981cited by this paper
• Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).

  1981cited by this paper
• Anaphylactic actions of platelet-activating factor.

  1981cited by this paper
• Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

  1980cited by this paper
• Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.

  1979cited by this paper

• Impact of targeting the platelet-activating factor and its receptor in cancer treatment

  2025cites this paper
• Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives

  2019cites this paper
• A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?

  2017cites this paper
• Macromolecule Permeability in Rodent Intestine following Thermal Injury and Lipopolysaccharide Challenge

  2013cites this paper
• The Significance of Endothelin in Platelet-Activating Factor–Induced Fetal Growth Restriction

  2012cites this paper
• PLATELET-ACTIVATING FACTOR AND HYPERACUTE REJECTION

  2010cites this paper
• Inhaled Nitric Oxide Prevents Experimental Platelet Activating Factor\p=n-\InducedShock

  2008cites this paper
• Lipid Mediators of Tumor Necrosis Facfor-a-lnduced Uveitis

  2005cites this paper
• Infusion of Exogenous Platelet-Activating Factor Produces Intrauterine Growth Restriction in the Rat

  2003cites this paper
• More Comments on “ Keeping a Cool Head ”

  2002cites this paper
• Platelet-Activating Factor

  2000cites this paper
• Hemodynamic effects of platelet-activating factor in nonpregnant and pregnant sheep.

  1999cites this paper
• Hemodynamic effects of platelet-activating factor in nonpregnant and pregnant sheep.

  1999cites this paper
• Biosynthetic Inhibitors and Receptor Antagonists to Platelet Activating Factor

  1997cites this paper
• Inhaled nitric oxide prevents experimental platelet activating factor-induced shock.

  1996cites this paper
• The role of platelet-activating factor in lipopolysaccharide-induced myocardial depression in guinea pigs.

  1995cites this paper
• Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.

  1994cites this paper
• Inflammatory mediators and intestinal injury.

  1994cites this paper
• Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.

  1994cites this paper
• Platelet-Activating Factor: Pathophysiological Changes and Therapeutic Implications in Sepsis

  1994cites this paper
• Platelet-activating factor antagonists and implantation in rabbits.

  1994cites this paper
• Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemia.

  1993cites this paper
• Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonists.

  1993cites this paper
• Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring.

  1993cites this paper
• [Effects of PAF antagonists in experimental models. Therapeutical perspectives].

  1993cites this paper
• Platelet Activating Factor: Rationale for the Use of PAF-Antagonists in Sepsis

  1992cites this paper
• Pulmonary vascular reactivity: effect of PAF and PAF antagonists.

  1992cites this paper
• A novel class of platelet activating factor (PAF) antagonists. II. Modification of the 2-position of the glycerol backbone of PAF-sulfonamide isosteres.

  1992cites this paper
• Effect of chronic interleukin-2 treatment on RES phagocytic activity in the rat.

  1992cites this paper
• Protective effect of SR 27417, a novel PAF antagonist, on PAF- or endotoxin-induced hypotension in the rat and the guinea-pig.

  1992cites this paper
• Cardiovascular effects of Acanthaster planci venom in the rat: possible involvement of PAF in its hypotensive effect.

  1992cites this paper
• PAF acether release on antigenic challenge

  1992cites this paper
• Platelet activating factor (PAF) antagonists contained in medicinal plants: lignans and sesquiterpenes.

  1992cites this paper
• A novel class of platelet activating factor (PAF) antagonists. I. Synthesis and structure-activity studies on PAF-sulfonamide isosteres.

  1992cites this paper
• Analogues of platelet activating factor. 6. Mono- and bis-aryl phosphate antagonists of platelet activating factor.

  1992cites this paper
• Analogues of platelet activating factor. 7. Bis-aryl amide and bis-aryl urea receptor antagonists of PAF.

  1992cites this paper
• Synthesis and pharmacology of a novel class of long-lasting PAF receptor antagonists.

  1991cites this paper
• Platelet-activating factor induces intestinal necrosis, but not septic shock, in germ-free and specific-pathogen-free rodents.

  1991cites this paper
• Lipid mediators of tumor necrosis factor-alpha-induced uveitis.

  1991cites this paper
• Inhibition of immune complex-induced enteropathy by three different platelet-activating factor receptor antagonists.

  1991cites this paper
• Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo.

  1991cites this paper
• Hypoxia, PAF, and necrotizing enterocolitis

  1991cites this paper
• Effect of platelet activating factor on reticuloendothelial system function.

  1991cites this paper
• Sustained Effects of Platelet-Activating Factor Infusion in Piglets

  1991cites this paper
• Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice.

  1991cites this paper
• The Involvement of Paf in Thrombotic Events

  1991cites this paper
• Effect of platelet activating factor on reticulo-endothelial system function

  1991cites this paper
• Disubstituted tetrahydrofurans and dioxolanes and PAF antagonists.

  1991cites this paper
• Production of platelet-activating factor by the pre-implantation sheep embryo.

  1991cites this paper
• Oxidative metabolism of energy substrates by preimplantation mouse embryos in the presence of platelet-activating factor.

  1990cites this paper
• Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.

  1990cites this paper
• PLATELET‐ACTIVATING FACTOR AND HYPERACUTE REJECTION: THE EFFECT OF A PLATELET‐ACTIVATING FACTOR ANTAGONIST, SRI 63–441, ON REJECTION OF XENOGRAFTS AND ALLOGRAFTS IN SENSITIZED HOSTS

  1990cites this paper
• Antagonists of embryo-derived platelet-activating factor act by inhibiting the ability of the mouse embryo to implant.

  1990cites this paper
• Implantation potential and fetal viability of mouse embryos cultured in media supplemented with platelet-activating factor.

  1990cites this paper
• Indirect inhibition of myocyte RNA and protein synthesis by interleukin-1.

  1990cites this paper
• Inflammatory exudates in skin windows induced by 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine.

  1990cites this paper
• WEB 2086, a novel specific PAF antagonist, prevents PAF induced arrhythmogenicity.

  1990cites this paper
• Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo

  1990cites this paper
• Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor (PAF-acether).

  1990cites this paper
• Preclinical and clinical pharmacology of platelet‐activating factor receptor antagonists

  1990cites this paper
• [Platelet activating factor--a biologically active phospholipid].

  1990cites this paper
• Inflammatory exudates in skin windows induced by 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine.

  1990cites this paper
• XENOGRAFTS AND ALLOGRAFTS IN SENSITIZED HOSTS

  1990cites this paper
• A Role for Platelet Activation Factor in Embryo Implantation

  1990cites this paper
• In vivo method for the assessment of platelet accumulation.

  1989cites this paper
• Synthesis and antagonistic activities of enantiomers of cyclic platelet-activating factor analogues.

  1989cites this paper
• Roles of Platelet-Activating Factor and Thromboxane in Group B Streptococcus-Induced Pulmonary Hypertension in Piglets

  1989cites this paper
• Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.

  1989cites this paper
• Endothelium‐dependent vasodilator effects of platelet activating factor on rat resistance vessels

  1989cites this paper
• Lactone and cyclic ether analogues of platelet-activating factor. Synthesis and biological activities.

  1989cites this paper
• INHIBITION OF VASOCONSTRICTION BY PLATELET ACTIVATING FACTOR IN THE IN SITU BLOOD PERFUSED RAT MESENTERY

  1989cites this paper
• Effects of combined receptor antagonists of leukotriene D4 (LTD4) and platelet-activating factor (PAF) on rhesus airway responses to LTD4, PAF and antigen.

  1989cites this paper
• Vasopressin-induced pulmonary vasodilation in rats.

  1989cites this paper
• The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion.

  1989cites this paper
• RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release.

  1989cites this paper
• Inhibition of endotoxin-induced bacterial translocation in mice.

  1989cites this paper
• Pharmacological profile of 48740 R.P., a PAF-acether antagonist.

  1988cites this paper
• Effects of REV 5901, a 5‐lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea‐pig

  1988cites this paper
• Pharmacological Modulation of Platelet Activating Factor (PAF)‐induced Bronchoconstriction and Hypertension in Anaesthetized Guinea‐pigs

  1988cites this paper
• Influence of a platelet-activating factor antagonist on circulating levels of cyclosporine in the dog.

  1988cites this paper
• Lipoxygenase metabolites mediate increased airways resonsiveness to histamine after acute platelet activating factor exposure in the guinea-pig

  1988cites this paper
• Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites

  1988cites this paper
• Antagonists of embryo-derived platelet-activating factor prevent implantation of mouse embryos.

  1988cites this paper
• Platelet-activating factor-induced increases in glucose kinetics.

  1988cites this paper
• Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412.

  1988cites this paper
• Prostaglandin-independent inhibition of ocular vascular permeability by a platelet-activating factor antagonist.

  1988cites this paper
• Platelet-activating factor induces glycogen degradation in fetal rabbit lung in utero.

  1988cites this paper
• Effects of platelet-activating factor antagonist SRI 63-441 on endotoxemia in sheep.

  1988cites this paper
• Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dog.

  1987cites this paper
• In Vitro and In Vivo Pharmacological Profiles of the PAF Receptor Antagonist SRI 63-675

  1987cites this paper
• Embryo-derived platelet activating factor: a preimplantation embryo mediator of maternal recognition of pregnancy.

  1987cites this paper
• Negative inotropic effect of platelet-activating factor on human myocardium: a pharmacological study.

  1987cites this paper
• Inhibition by SRI 63-072 and SRI 63-119 of PAF-acether and immune complex effects in the guinea pig.

  1987cites this paper
• More Comments on "Keeping a Cool Head"

  1987cites this paper
• Platelet-activating factor antagonists.

  1987cites this paper
• Evaluation of the effect of a platelet activating factor antagonist on platelet activating factor and Ascaris antigen-induced airway responses in rhesus monkeys.

  1987cites this paper
• Prolongation of Pig‐to‐Dog Renal Xenograft Survival by Modification of the Inflammatory Mediator Response

  1987cites this paper
• Chapter 8 Pulmonary and Antiallergy Agents

  1987cites this paper
• Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.

  1987cites this paper
• The effect of FK-506 on hyperacute rejection in presensitized rats.

  1987cites this paper